Evidence map›Paper›PMID 22933707›Full record

ArticleMolecular cancer therapeutics2012

Smoking induces epithelial-to-mesenchymal transition in non-small cell lung cancer through HDAC-mediated downregulation of E-cadherin.

Nagaraj S Nagathihalli, Pierre P Massion, Adriana L Gonzalez, Pengcheng Lu, Pran K Datta

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cancer therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. International journal of environmental research and public health · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Smoking affects gene expression in blood of patients with ischemic stroke.Annals of clinical and translational neurology · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Nagaraj S NagathihalliDepartment of Medicine, University of Alabama at Birmingham, 1720 2nd Avenue South, 520 C, WTI, Birmingham, AL 35294, USA.
Pierre P Massion
Adriana L Gonzalez
Pengcheng Lu
Pran K Datta
University of Alabama at Birmingham · USVanderbilt University · US

Funding

TARGETING NOTCH 3 IN LUNG CANCERP50CA090949 · NCI · VANDERBILT UNIVERSITY · PI MASSION, PIERRE P. · 2001 to 2011
$24.1M
STRAP and Smad 7 Signaling in Colorectal CarcinomasR01CA095195 · NCI · VANDERBILT UNIVERSITY · PI DATTA, PRAN K · 2003 to 2013
$2.4M
Molecular Approaches to Early Detection of Lung CancerR01CA102353 · NCI · VANDERBILT UNIVERSITY · PI MASSION, PIERRE P. · 2005 to 2014
$2.4M
Targeting TGF-beta Signaling in Lung CancerR01CA113519 · NCI · VANDERBILT UNIVERSITY · PI DATTA, PRAN K · 2006 to 2010
$1.2M
NCI NIH HHS 5P50CA90949NCI NIH HHS CA113519NCI NIH HHS P50 CA090949NCI NIH HHS R01 CA095195NCI NIH HHS R01 CA102353NCI NIH HHS R01 CA113519NCI NIH HHS R01 CA95195
6 · The paper itself

Abstract

Epidemiological studies have shown that most cases of lung cancers (85%-90%) are directly attributable to tobacco smoking. Although association between cigarette smoking and lung cancer is well documented, surprisingly little is known about the molecular mechanisms of how smoking is involved in epithelial-to-mesenchymal transition (EMT) through epigenetic changes. Here, we show that lung cancer patients with a smoking history have low E-cadherin levels and loss of E-cadherin is a poor prognostic factor in smokers. Moreover, the downregulation of E-cadherin correlates with the number of pack years. In an attempt to determine the role of long-term cigarette smoking on EMT, we observed that treatment of lung cell lines with cigarette smoke condensate (CSC) induces EMT through downregulation of epithelial markers, including E-cadherin and upregulation of mesenchymal markers. CSC decreases E-cadherin expression at the transcriptional level through upregulation of LEF1 and Slug, and knockdown of these two proteins increases E-cadherin expression. Importantly, chromatin immunoprecipitation assays suggest that LEF-1 and Slug binding to E-cadherin promoter is important for CSC-mediated downregulation of E-cadherin. The histone deacetylase (HDAC) inhibitor MS-275 reverses CSC-induced EMT, migration, and invasion through the restoration of E-cadherin expression. These results suggest that recruitment of HDACs by transcriptional repressors LEF-1 and Slug is responsible for E-cadherin suppression and EMT in cigarette smokers and provide a potential drug target toward the treatment of lung cancer.

Indexed as

AcetylationAntigens, CDBenzamidesCadherinsCarcinoma, Non-Small-Cell LungCell MovementDown-RegulationEpigenesis, GeneticEpithelial-Mesenchymal TransitionGene Expression Regulation, NeoplasticHistone Deacetylase InhibitorsHistone DeacetylasesHumansLung NeoplasmsLymphoid Enhancer-Binding Factor 1Neoplasm InvasivenessAntigens, CDBenzamidesCadherinsCDH1 protein, humanentinostatHistone Deacetylase InhibitorsHistone DeacetylasesLEF1 protein, humanLymphoid Enhancer-Binding Factor 1PyridinesSNAI1 protein, humanSnail Family Transcription FactorsTranscription Factors

Identifiers

PMID22933707
PMCPMC3969334
OpenAlexW2119990770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.